68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors

Summary

This trial studies how well gallium Ga 68-edotreotide (68Ga-DOTA-TOC) positron emission tomography (PET)/computer tomography (CT) works in imaging participants with neuroendocrine tumors. 68Ga-DOTA-TOC is used as a tracer chemical during PET/CT scans. Diagnostic procedures, such as 68Ga-DOTA-TOC PET/CT, may help find and diagnose neuroendocrine tumors.

Timeline

Start

2017-05-16

Primary completion

2021-02-05

Completion

2021-02-05

Outcome

Outcome not reported

Stopped: “Per PI Request”

Drugs

Indications